Connect with us

Uncategorized

Hereditary cancers aren’t just a women’s problem. Jewish men need to take precautions too.

Bill Harris, a veteran Los Angeles photojournalist, didn’t think much of it when one morning in 2012 he woke up and found a tiny blood spot on the T-shirt he’d slept in. The next morning, he found blood in the same place on his chest — and went straight to his computer.

“Online, I could find only three things that would cause a man’s nipple to discharge blood: being an avid runner, which I wasn’t; having a subtropical fungus, which I didn’t; and breast cancer,” he said. “That was a pretty big shock.”

Harris, then just a few weeks shy of his 61st birthday, immediately called his doctor, who ordered a mammogram and ultrasound. They confirmed a cancerous growth in his right breast. Ten days later, a biopsy came back positive. The next month Harris got a right mastectomy, followed by the removal of his left breast half a year later.

“I walked into a woman’s imaging center and had to get into a pink paper robe,” he recalled. “All the women in the waiting room were staring at me.”

Like many other Ashkenazi men, Harris never had considered that he might have been born with a harmful mutation of the BRCA gene, which elevates the risk not only of breast cancer, but also of melanoma and prostate, ovarian and pancreatic cancer.

“Hundreds of other mutations in the BRCA gene are just as dangerous, but they’re not specific to Ashkenazim,” said Dr. Robert Sidlow, director of the Male BRCA Genetic Risk Program at New York’s Memorial Sloan Kettering Cancer Center. About 1 in 40 Ashkenazi Jews (those of Eastern European descent) carries the harmful mutation, compared to about 1 in 400 in the general population.

“The vast majority of patients I see are relatives of women who have breast or ovarian cancer and then get tested,” he said. Of BRCA mutation carriers, Sidlow added, “Most men are pretty happy to enroll in some kind of surveillance program once they get over the initial shock.”

Sidlow is on the Men’s Leadership Council at Sharsheret, the national Jewish nonprofit organization that educates the community about cancer risks and supports those with breast cancer and ovarian cancer.

Elana Silber, CEO of Sharsheret (Hebrew for “chain”), says it’s crucial that men with a family history of cancer undergo genetic counseling screening for BRCA and other hereditary cancer mutations.

Genetic testing is possible via a standard blood or saliva sample.

While Sharsheret is primarily considered a women’s organization, it has been using November — nicknamed Movember for its focus on men’s health — for an awareness campaign focused on Jewish men’s cancer risks.

“This is not only a women’s issue,” Silber said. “Family history is so important. When a man shares his family history with his doctor, he may not realize that he should mention that his mother had breast cancer or that his sister had ovarian cancer, as these are not generally ‘men’s diseases.’ They are not aware that these cancers could mean that they themselves are at increased risk for cancer and that they can pass on these mutations to the next generation – their daughters and their sons.”

If someone discovers he (or she) is a carrier of one of the genetic mutations with elevated cancer risks — not just BRCA but also such mutations as ATM, TP53, CHEK2, and PALB2 — there are various precautions they can take for themselves and their children. They can monitor their own health more closely, they can get encourage their children to test to see if they are carriers and, for any future children, take steps to prevent the mutated genes from being passed down.

For example, couples can conceive via in vitro fertilization, or IVF, and then test the embryos before implantation to ensure that only those unaffected by the genetic mutation are implanted.

While most women are aware of the risks of breast cancer, men generally are not — even though the disease strikes 2,500 men in the U.S. every year and kills about 500 of them, according to Sidlow. About 1-2% of men with the BRCA1 mutation and 6-7% of men with the BRCA2 mutation will develop cancer by age 80.

“This is why we recommend periodic mammograms starting at about age 50 for men who carry a BRCA2 mutation,” Sidlow said. “We like to educate these men on how to check their chests once a month and have a clinician do a breast checkup on them once a year.”

Since the BRCA1 and BRCA2 mutations also make prostate cancer more likely, men with either mutation should get PSA (prostate-specific antigen) levels in their blood tested annually beginning at age 40, rather than 50, the age at which screening generally begins, Sidlow said.

Sharsheret has been promoting the importance of learning one’s family history, genetic counseling and screening among both men and women. The 20-year-old organization also runs various peer support networks, offers financial assistance to cancer patients, provides mental health counseling and guidance to patients, caregivers, and their friends, and seeks to educate the broader Jewish community about cancer risks and support.

Peggy Cottrell, a certified genetic counselor at Sharsheret, said men in general are more reluctant to get regular checkups than women.

Ashkenazi Jewish men are at elevated risk not just of breast and prostate cancer but also of pancreatic cancer. Pancreatic cancer is particularly difficult because it’s tough to detect early enough and hard to treat. The five-year survival rate is only 11%. About 2% of BRCA1 carriers and 4% of BRCA2 carriers will develop pancreatic cancer, Sidlow estimated.

“Usually by the time pancreas cancer is clinically detected it has already spread microscopically to the liver,” Sidlow said. “But pancreas cancer is potentially curable if caught when the tumor is extremely small.”

Even among those with elevated risks, certain behaviors can improve one’s odds, such as avoiding obesity, smoking and excessive alcohol consumption.

Harris, the California photojournalist, is still fighting at age 71. While he overcame breast cancer 10 years ago, last year he was diagnosed with ampullary cancer, a rare disease related to his BRCA2 status that was discovered thanks to his participation in a UCLA study. Surgeons have removed his gall bladder, half his pancreas and part of his small intestine, and he has had to endure eight rounds of chemotherapy.

“I’m still working through the aftereffects of the chemo. I have to eat smaller quantities than before and take enzymes to supplement my digestive processes,” Harris said.

Meanwhile, his 37-year-old son discovered that he, too, carries the BRCA2 mutation, and he had a double prophylactic mastectomy and reconstruction at age 30 — just to be on the safe side.

“If there’s any history of breast, ovarian or prostate cancer in your family, get tested genetically so that you’re informed,” Harris advised. “Diagnoses happen way too late for men, and the danger is too big.”


The post Hereditary cancers aren’t just a women’s problem. Jewish men need to take precautions too. appeared first on Jewish Telegraphic Agency.

Continue Reading

Uncategorized

Trump Says US Will Sell F-35s to Saudi Arabia Ahead of White House Talks With Crown Prince

US President Donald Trump and Saudi Crown Prince and Prime Minister Mohammed Bin Salman shake hands during a Memorandum of Understanding (MOU) signing ceremony at the Royal Court in Riyadh, Saudi Arabia, May 13, 2025. Photo: REUTERS/Brian Snyder

US President Donald Trump on Monday said he plans to approve the sale of US-made F-35 fighter jets to Saudi Arabia, announcing his intention one day before he hosts Saudi Crown Prince Mohammed bin Salman at the White House in Washington, DC.

The high-stakes meeting comes as rumors swirl about the possibility of Israel and Saudi Arabia, long-time foes who in recent years have increasingly cooperated behind closed doors, normalizing ties under a US-brokered deal.

“They want to buy. They are a great ally. I will say that we will be doing that,” Trump told reporters in the Oval Office. “We will be selling them F-35s.”

Reuters reported earlier this month that Saudi Arabia has requested to buy as many as 48 F-35 fighter jets in a potential multibillion-dollar deal that cleared a key Pentagon hurdle.

Such a sale would be a policy shift for Washington, which primarily sells the F-35 to formal military allies, such as NATO members or Japan. Israel is the only country in the Middle East that has the elite fighter jets, in accordance with longstanding bipartisan policy for US administrations and the Congress to maintain Israel’s “qualitative military edge” in the region. Saudi Arabia’s acquiring them would at least somewhat change the military balance of power.

However, Axios reported over the weekend that Israel does not oppose the US sale of F-35s to Saudi Arabia, the world’s top oil producer — as long as it’s conditioned on Riyadh normalizing relations with Jerusalem.

“We told the Trump administration that the supply of F-35s to Saudi Arabia needs to be subject to Saudi normalization with Israel,” an anonymous Israeli official told the news outlet, adding that giving the fighter jets without getting any significant diplomatic progress would be “a mistake and counterproductive.”

It has been widely reported that Israel and Saudi Arabia were on the verge of a deal to establish formal diplomatic ties until the discussions were derailed by Hamas’s Oct. 7, 2023, massacre across southern Israel and the ensuing war in Gaza. Saudi officials have said that they will only agree to a normalization deal if Israel commits to a path toward a Palestinian state.

Saudi Arabia’s close partners Bahrain and the United Arab Emirates were among the Arab states to normalize ties with Israel in 2020 as part of the Trump-brokered Abraham Accords. Trump has said he is intent on expanding the accords to include other countries, above all Saudi Arabia.

“I hope that Saudi Arabia will be going into the Abraham Accords fairly shortly,” Trump told reporters on Friday.

The F-35 deal and possible Israeli-Saudi normalization are expected to be central to the agenda when bin Salman, widely known by his initials MBS, meets Trump.

It will be the crown prince’s first trip to the US since the death of prominent Saudi critic Jamal Khashoggi by Saudi agents in Istanbul in 2018. US intelligence concluded that bin Salman approved the capture or killing of Khashoggi, although Saudi Arabia’s de facto leader has denied ordering the operation.

Seven years later, Washington and Riyadh, longtime strategic partners, are looking forward, with bin Salman set to receive full ceremonial honors at the White House. Their meeting comes six months after Trump secured a $600 billion commitment from Saudi Arabia to invest in the United States.

Beyond investment, Riyadh has been eager to reach a security agreement with Washington expanding arms sales such as advanced missile-defense systems and drones, and deeper military training partnerships. Most importantly for Riyadh, however, is the US offering certain guarantees ensuring the kingdom’s security. Many observers have suggested that such a defense deal could be part of a broader arrangement to broker Saudi-Israel normalization.

Trump and bin Salman are also expected to discuss broadening ties in commerce, technology, and potentially nuclear energy.

Continue Reading

Uncategorized

Catholic Church in Berlin Condemns Antisemitism as Anti-Israel Agitators Vandalize Historic Crucifix

Illustrative: Hamas supporters at a rally in Cologne, Germany, on Oct. 22, 2023. Photo: Reuters/Ying Tang

As antisemitic incidents continue to rise in Germany, the Catholic Church in Berlin has taken a firmer stance against anti-Jewish hatred by issuing new guidelines prohibiting its members from expressing racist, antisemitic, or extremist views.

On Saturday, the Archdiocese of Berlin, the governing body of the city’s Catholic Church, announced that all candidates for leadership positions must sign a special declaration rejecting racism, antisemitism, and extremist views. 

“With this decision, responsibility falls where it belongs. Anyone seeking to serve on the diocesan committees and run in the elections must actively uphold the values of our Church,” Karlies Abmeier, president of the Diocesan Council, said in a statement. 

The Catholic Church’s latest move aims to ensure that anyone seeking a leadership role within the institution commits to rejecting “racism, antisemitism, ethnic nationalism, and hostility toward democracy.”

“It is crucial for us that such statements never come from those in positions of power within our Church,” Marcel Hoyer, executive director of the committee, told the German Press Agency.

Candidates would also be prohibited from belonging to any party or organization that the German Office for the Protection of the Constitution has designated as extremist.

The archdiocese’s announcement comes amid a climate of rising hostility and radicalization in Germany, where the local Jewish community has increasingly become a target. 

Last week, anti-Israel protesters vandalized a church with paint in the Vogelsberg district of Hesse in central Germany.

According to local media reports, a crucifix was vandalized with antisemitic graffiti, including the slogans “Free Palestine” and “Jesus is Palestinian,” and the church walls were also defaced with red paint.

Pastor Ingmar Bartsch denounced the incident, describing himself as “angry and bewildered.”

“What affects me most is that it’s a historic depiction of Jesus, at least 200 to 300 years old, and truly one of a kind,” Bartsch told the German newspaper Bild.

He explained that the crucifix will require a professional restoration, with initial damage estimates reaching into the thousands of dollars.

Local police have launched an investigation into the incident as a case of property damage, noting that the items involved hold religious significance.

As the restoration process begins, Bartsch said the church will remain closed for now, reopening only for religious services.

Continue Reading

Uncategorized

Columbia University Rejects Latest Israel Divestment Proposal

Columbia University on Sept. 2, 2025. Photo: REUTERS/Ryan Murphy

Columbia University said on Friday that it will not divest from Israel and other corporations which anti-Zionist activists denounced for selling materials to the Israeli military.

The university’s Advisory Committee on Socially Responsible Investing (ACSRI) stated its position on the matter as a response to a group which submitted three proposals calling for the policy in December 2024, when the institution’s campus was being roiled by anti-Israel protests and a deluge of antisemitic incidents. The group had charged that Israel is guilty of “human rights violations” and “war crimes.”

Israel argued it went to unprecedented lengths to try and avoid civilian casualties during the latest war in Gaza, noting its efforts to evacuate areas before it targeted them and to warn residents of impending military operations with leaflets, text messages, and other forms of communication. It noted that Hamas, the Palestinian terrorist group it was targeting, embedded its fighters within Gaza’s civilian population and commandeered civilian facilities like hospitals, schools, and mosques to run operations and direct attacks.

In three separate statements, Columbia said that the group behind the boycott proposals lacks consensus support on campus and has reduced one of the most complex geopolitical conflicts in the world history to “vague and excessively broad” categories, sewing partisan division and confusion where a university would, ideally, aim to promote clarity and sober analysis of fact.

Additionally, ASCRI said that the group’s proposals are of “similar … substance” to other ideas put forth by the notorious Columbia University Apartheid Divest (CUAD) group, a spinoff of Students for Justice in Palestine (SJP) which Columbia resolved neither to recognize nor correspond with due to its culpability in antisemitic assaults, hate speech, and a slew of illegal occupations of campus property.

“As noted in the ASCRI’s decision on the CUAD proposal last year, members of the university have a wide range of views on contentious issues,” ASCRI wrote. “Hence, it will be difficult or unprecedented for the university, with such diverse views, to sponsor shareholder proposals of the kind this proposal envisages.”

It added, “There is significant opposition in the Columbia University community to divesting from companies that are involved in Israel, as evidenced by the actions of many students, faculty, and alumni.”

Columbia University has begun implementing a series of reforms it says will address campus antisemitism.

In a statement issued in July, university president Claire Shipman said the institution will hire new coordinators to oversee complaints alleging civil rights violations; facilitate “deeper education on antisemitism” by creating new training programs for students, faculty, and staff; and adopt the International Holocaust Remembrance Alliance (IHRA) definition of antisemitism — a tool that advocates say is necessary for identifying what constitutes antisemitic conduct and speech.

Shipman also announced new partnerships with the Anti-Defamation League (ADL) and other Jewish groups while delivering a major blow to the anti-Zionist movement on campus by vowing never to “recognize or meet with” CUAD, a pro-Hamas campus group which has serially disrupted academic life with unauthorized, surprise demonstrations attended by non-students.

“I would also add that making these announcements in no way suggests we are finished with the work,” Shipman continued. “In a recent discussion, a faculty member and I agreed that antisemitism at this institution has existed, perhaps less overtly, for a long while, and the work of dismantling it, especially through education and understanding will take time. It will likely require more reform. But I’m hopeful that in doing this work, as we consider and even debate it, we will start to promote healing and to chart our path forward.”

Columbia University had, until that point, yielded some of the most indelible examples of anti-Jewish hatred in higher education since Hamas’s Oct. 7, 2023, massacre in southern Israel set off explosions of anti-Zionist activity at colleges and universities across the US. Such incidents included a student who proclaimed that Zionist Jews deserve to be murdered and are lucky he is not doing so himself and administrative officials who, outraged at the notion that Jews organized to resist anti-Zionism, participated in a group chat in which each member took turns sharing antisemitic tropes that described Jews as privileged and grafting.

Amid these incidents, the university struggled to contain CUAD, which in late January committed infrastructural sabotage by flooding the toilets of the Columbia School of International and Public Affairs (SIPA) with concrete. Numerous reports indicate the attack may have been the premeditated result of planning sessions which took place many months ago at an event held by Alpha Delta Phi (ADP) — a literary society, according to the Washington Free Beacon. During the event, ADP reportedly distributed literature dedicated to “aspiring revolutionaries” who wish to commit seditious acts. Additionally, a presentation was given in which complete instructions for the exact kind of attack which struck Columbia were shared with students.

Columbia has since paid over $200 million to settle claims that it exposed Jewish students, faculty, and staff to antisemitic discrimination and harassment — a deal which secures the release of over $1 billion dollars the Trump administration impounded to pressure the institution to address the issue.

“Columbia’s reforms are a roadmap for elite universities that wish to retain the confidence of the American public by renting their commitment to truth-seeking, merit, and civil debate,” US Education Secretary Linda McMahon McMahon said at the time. “I believe they will ripple across the higher education sector and change the course of campus culture for years to come.”

Follow Dion J. Pierre @DionJPierre.

Continue Reading

Copyright © 2017 - 2023 Jewish Post & News